You are here

PREMIUM

No easy way out for Abbott as deal target faces bribery probe

Minneapolis

ABBOTT Laboratories tried to end its US$5.8 billion agreement to buy Alere Inc after finding out in mid- March that the medical-testing company was swept up in a US probe of bribery overseas. Alere's shares, meanwhile, are trading at levels suggesting that investors have their...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes